By Shania Kennedy
June 04, 2024 – A research team from Moffitt Cancer Center and the University of Oxford has created a deep learning framework to help personalize adaptive therapy schedules for patients with prostate cancer.
The…
What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
The modern landscape of clinical trials is expanding to include hybrid and decentralized approaches to conducting research. As the methods of conducting clinical trials diversify, clinical trial logistics also increase in complexity. In 2024,…
Continue Reading
An NHS England analysis of the effectiveness of virtual wards has found that black and ethnic minority people are underrepresented in patient cohorts.The evaluation, published on 16 May 2024, comes as NHS England announces…
Continue Reading
Introduction to Paige’s Innovative Approach
Overview of Paige’s New Service Line
Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) applications has announced a groundbreaking new service line. This service is centered…
Building trust and collaboration between payers and providers is crucial for managing healthcare costs and providing a better patient experience. During the K2 Collaborative Summit, a keynote panel provided key insights on building effective…
Continue Reading
Introduction to AI in Predicting Autoimmune Diseases
The Emergence of EXPRESSO
The advancement of artificial intelligence (AI) in the field of medical research has led to groundbreaking developments, particularly in the prediction and understanding of autoimmune…
What You Should Know:
– PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
– …
Continue Reading
What You Should Know:
– Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to…
Continue Reading
By Shania Kennedy
May 29, 2024 – A research team from Pennsylvania State University has developed an AI model to gain insight into how gene expression impacts autoimmune disease risk, according to a study published recently…
Continue Reading
